DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3

Journal of Experimental Medicine

Volumn 212, Issue 6, 2015, Pages 953-970

  Thompson, Benjamin J ^a   Bhansali, Rahul ^a   Diebold, Lauren ^a   Cook, Daniel E ^a   Stolzenburg, Lindsay ^a   Casagrande, Anne Sophie ^c   Besson, Thierry ^d   Leblond, Bertrand ^c   Désiré, Laurent ^c   Malinge, Sébastien ^b   Crispino, John D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c Diaxonhit   (France)

^d UNIVERSITÉ ET INSA DE ROUEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D3; DUAL SPECIFICITY TYROSINE REGULATED KINASE 1A; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG; CCND3 PROTEIN, MOUSE; DYRK KINASE; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ARTICLE; CELL MATURATION; CONTROLLED STUDY; ENZYME INHIBITION; GENE INACTIVATION; GENETIC TRANSCRIPTION; LYMPHOCYTE PROLIFERATION; LYMPHOID CELL; LYMPHOPOIESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; ALLELE; ANIMAL; B LYMPHOCYTE; BONE MARROW CELL; C57BL MOUSE; CELL PROLIFERATION; CYTOLOGY; EXON; FEMALE; FLOW CYTOMETRY; GENE LIBRARY; GENOTYPE; HEK293 CELL LINE; HUMAN; KNOCKOUT MOUSE; MALE; METABOLISM; MUTATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ALLELES; ANIMALS; B-LYMPHOCYTES; BONE MARROW CELLS; CELL PROLIFERATION; CYCLIN D3; E2F TRANSCRIPTION FACTORS; EXONS; FEMALE; FLOW CYTOMETRY; GENE LIBRARY; GENOTYPE; HEK293 CELLS; HUMANS; LYMPHOPOIESIS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC;

EID: 84973317381     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20150002     Document Type: Article

References (57)

1. Allen, J.J., M. Li, C.S. Brinkworth, J.L. Paulson, D. Wang, A. Hübner, W.H. Chou, R.J. Davis, A.L. Burlingame, R.O. Messing, et al. 2007. A semisynthetic epitope for kinase substrates. Nat. Methods. 4:511-516. http://dx.doi.org/10.1038/nmeth1048
2. Aranda, S., M. Alvarez, S. Turró, A. Laguna, and S. de la Luna. 2008. Sprouty2- mediated inhibition of fibroblast growth factor signaling is modulated by the protein kinase DYRK1A. Mol. Cell. Biol. 28:5899-5911. http:// dx.doi.org/10.1128/MCB.00394-08
3. Barallobre, M.J., C. Perier, J. Bové, A. Laguna, J.M. Delabar, M. Vila, and M.L. Arbonés. 2014. DYRK1A promotes dopaminergic neuron survival in the developing brain and in a mouse model of Parkinson's disease. Cell Death Dis. 5:e1289. http://dx.doi.org/10.1038/cddis.2014 .253
4. Barbash, O., E. Egan, L.L. Pontano, J. Kosak, and J.A. Diehl. 2009. Lysine 269 is essential for cyclin D1 ubiquitylation by the SCF(Fbx4/alphaB-crystallin) ligase and subsequent proteasome-dependent degradation. Oncogene. 28:4317-4325. http://dx.doi.org/10.1038/onc.2009.287
5. Becker, W. 2012. Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control. Cell Cycle. 11:3389-3394. http://dx.doi.org/10.4161/cc.21404
6. Casanovas, O., M. Jaumot, A.B. Paules, N. Agell, and O. Bachs. 2004. P38SAPK2 phosphorylates cyclin D3 at Thr-283 and targets it for proteasomal degradation. Oncogene. 23:7537-7544. http://dx.doi.org/10.1038/sj .onc.1208040
7. Chen, J.Y., J.R. Lin, F.C. Tsai, and T. Meyer. 2013. Dosage of Dyrk1a shifts cells within a p21-cyclin D1 signaling map to control the decision to enter the cell cycle. Mol. Cell. 52:87-100. http://dx.doi.org/10 .1016/j.molcel.2013.09.009
8. Chen, C.K., C. Bregere, J. Paluch, J.F. Lu, D.K. Dickman, and K.T. Chang. 2014. Activity-dependent facilitation of Synaptojanin and synaptic vesicle recycling by the Minibrain kinase. Nat. Commun. 5:4246. http://dx.doi .org/10.1038/ncomms5246
9. Clark, M.R., M. Mandal, K. Ochiai, and H. Singh. 2014. Orchestrating B cell lymphopoiesis through interplay of IL-7 receptor and pre-B cell receptor signalling. Nat. Rev. Immunol. 14:69-80. http://dx.doi.org/10 .1038/nri3570
10. Cooper, A.B., C.M. Sawai, E. Sicinska, S.E. Powers, P. Sicinski, M.R. Clark, and I. Aifantis. 2006. A unique function for cyclin D3 in early B cell development. Nat. Immunol. 7:489-497. http://dx.doi.org/10.1038/ni1324
11. de Graaf, K., H. Czajkowska, S. Rottmann, L.C. Packman, R. Lilischkis, B. Lüscher, and W. Becker. 2006. The protein kinase DYRK1A phosphorylates the splicing factor SF3b1/SAP155 at Thr434, a novel in vivo phosphorylation site. BMC Biochem. 7:7. http://dx.doi.org/10 .1186/1471-2091-7-7
12. Di Vona, C., D. Bezdan, A.B. Islam, E. Salichs, N. López-Bigas, S. Ossowski, and S. de la Luna. 2015. Chromatin-wide profiling of DYRK1A reveals a role as a gene-specific RNA polymerase II CTD kinase. Mol. Cell. 57:506-520. http://dx.doi.org/10.1016/j.molcel.2014.12.026
13. Dowjat, K., T. Adayev, W. Kaczmarski, J. Wegiel, and Y.W. Hwang. 2012. Gene dosage-dependent association of DYRK1A with the cytoskeleton in the brain and lymphocytes of down syndrome patients. J. Neuropathol. Exp. Neurol. 71:1100-1112. http://dx.doi.org/10.1097/ NEN.0b013e31827733c8
14. Forristal, C., S.A. Henley, J.I. MacDonald, J.R. Bush, C. Ort, D.T. Passos, S. Talluri, C.A. Ishak, M.J. Thwaites, C.J. Norley, et al. 2014. Loss of the mammalian DREAM complex deregulates chondrocyte proliferation. Mol. Cell. Biol. 34:2221-2234. http://dx.doi.org/10.1128/MCB .01523-13
15. Foucourt, A., D. Hédou, C. Dubouilh-Benard, L. Désiré, A.S. Casagrande, B. Leblond, N. Loäec, L. Meijer, and T. Besson. 2014a. Design and synthesis of thiazolo[5,4-f]quinazolines as DYRK1A inhibitors, part I. Molecules. 19:15546-15571. http://dx.doi.org/10.3390/molecules191015546
16. Foucourt, A., D. Hédou, C. Dubouilh-Benard, A. Girard, T. Taverne, A.S. Casagrande, L. Désiré, B. Leblond, and T. Besson. 2014b. Design and synthesis of thiazolo[5,4-f]quinazolines as DYRK1A inhibitors, part II. Molecules. 19:15411-15439. http://dx.doi.org/10.3390/molecules191015411
17. Funakoshi, E., T. Hori, T. Haraguchi, Y. Hiraoka, J. Kudoh, N. Shimizu, and F. Ito. 2003. Overexpression of the human MNB/DYRK1A gene induces formation of multinucleate cells through overduplication of the centrosome. BMC Cell Biol. 4:12. http://dx.doi.org/10.1186/1471- 2121-4-12
18. Guo, X., J.G. Williams, T.T. Schug, and X. Li. 2010. DYRK1A and DYRK3 promote cell survival through phosphorylation and activation of SIRT1. J. Biol. Chem. 285:13223-13232. http://dx.doi.org/10.1074/ jbc.M110.102574
19. Gwack, Y., S. Sharma, J. Nardone, B. Tanasa, A. Iuga, S. Srikanth, H. Okamura, D. Bolton, S. Feske, P.G. Hogan, and A. Rao. 2006. A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT. Nature. 441:646-650. http://dx.doi.org/ 10.1038/nature04631
20. Hämmerle, B., E. Ulin, J. Guimera, W. Becker, F. Guillemot, and F.J. Tejedor. 2011. Transient expression of Mnb/Dyrk1a couples cell cycle exit and differentiation of neuronal precursors by inducing p27KIP1 expression and suppressing NOTCH signaling. Development. 138:2543- 2554. http://dx.doi.org/10.1242/dev.066167
21. Hennet, T., F.K. Hagen, L.A. Tabak, and J.D. Marth. 1995. T-cell-specific deletion of a polypeptide N-acetylgalactosaminyl-transferase gene by site-directed recombination. Proc. Natl. Acad. Sci. USA. 92:12070-12074. http://dx.doi.org/10.1073/pnas.92.26.12070
22. Hobeika, E., S. Thiemann, B. Storch, H. Jumaa, P.J. Nielsen, R. Pelanda, and M. Reth. 2006. Testing gene function early in the B cell lineage in mb1-cre mice. Proc. Natl. Acad. Sci. USA. 103:13789-13794. http:// dx.doi.org/10.1073/pnas.0605944103
23. Hoffmann, R., T. Seidl, M. Neeb, A. Rolink, and F. Melchers. 2002. Changes in gene expression profiles in developing B cells of murine bone marrow. Genome Res. 12:98-111. http://dx.doi.org/10.1101/gr.201501
24. Huang, D.W., B.T. Sherman, Q. Tan, J. Kir, D. Liu, D. Bryant, Y. Guo, R. Stephens, M.W. Baseler, H.C. Lane, and R.A. Lempicki. 2007. DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res. 35(Web Server):W169-75. http://dx.doi.org/10.1093/nar/ gkm415
25. Inaba, H., M. Greaves, and C.G. Mullighan. 2013. Acute lymphoblastic leukaemia. Lancet. 381:1943-1955. http://dx.doi.org/10.1016/S0140- 6736(12)62187-4
26. Johnson, K., T. Hashimshony, C.M. Sawai, J.M. Pongubala, J.A. Skok, I. Aifantis, and H. Singh. 2008. Regulation of immunoglobulin lightchain recombination by the transcription factor IRF-4 and the attenuation of interleukin-7 signaling. Immunity. 28:335-345. http://dx.doi .org/10.1016/j.immuni.2007.12.019
27. Laguna, A., M.J. Barallobre, M.A. Marchena, C. Mateus, E. Ramírez, C. Martínez-Cue, J.M. Delabar, M. Castelo-Branco, P. de la Villa, and M.L. Arbonés. 2013. Triplication of DYRK1A causes retinal structural and functional alterations in Down syndrome. Hum. Mol. Genet. 22:2775-2784. http://dx.doi.org/10.1093/hmg/ddt125
28. Låhne, H.U., M.M. Kloster, S. Lefdal, H.K. Blomhoff, and S. Naderi. 2006. Degradation of cyclin D3 independent of Thr-283 phosphorylation. Oncogene. 25:2468-2476. http://dx.doi.org/10.1038/sj.onc .1209278
29. Lees, J.A., M. Saito, M. Vidal, M. Valentine, T. Look, E. Harlow, N. Dyson, and K. Helin. 1993. The retinoblastoma protein binds to a family of E2F transcription factors. Mol. Cell. Biol. 13:7813-7825.
30. Litovchick, L., L.A. Florens, S.K. Swanson, M.P. Washburn, and J.A. DeCaprio. 2011. DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly. Genes Dev. 25:801-813. http://dx.doi.org/10.1101/gad.2034211
31. Liu, P., N.A. Jenkins, and N.G. Copeland. 2003. A highly efficient recombineering- based method for generating conditional knockout mutations. Genome Res. 13:476-484. http://dx.doi.org/10.1101/gr.749203
32. Liu, Q., N. Liu, S. Zang, H. Liu, P. Wang, C. Ji, and X. Sun. 2014. Tumor suppressor DYRK1A effects on proliferation and chemoresistance of AML cells by downregulating c-Myc. PLoS ONE. 9:e98853. http:// dx.doi.org/10.1371/journal.pone.0098853
33. Maenz, B., P. Hekerman, E.M. Vela, J. Galceran, and W. Becker. 2008. Characterization of the human DYRK1A promoter and its regulation by the transcription factor E2F1. BMC Mol. Biol. 9:30. http://dx.doi .org/10.1186/1471-2199-9-30
34. Malinge, S., M. Bliss-Moreau, G. Kirsammer, L. Diebold, T. Chlon, S. Gurbuxani, and J.D. Crispino. 2012. Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome. J. Clin. Invest. 122:948-962. http:// dx.doi.org/10.1172/JCI60455
35. Mandal, M., S.E. Powers, K. Ochiai, K. Georgopoulos, B.L. Kee, H. Singh, and M.R. Clark. 2009. Ras orchestrates exit from the cell cycle and lightchain recombination during early B cell development. Nat. Immunol. 10:1110-1117. http://dx.doi.org/10.1038/ni.1785
36. Mao, X., Y. Fujiwara, A. Chapdelaine, H. Yang, and S.H. Orkin. 2001. Activation of EGFP expression by Cre-mediated excision in a new ROSA26 reporter mouse strain. Blood. 97:324-326. http://dx.doi.org/10 .1182/blood.V97.1.324
37. Michie, A.M., and J.C. Zúñiga-Pflücker. 2002. Regulation of thymocyte differentiation: pre-TCR signals and beta-selection. Semin. Immunol. 14:311-323. http://dx.doi.org/10.1016/S1044-5323(02)00064-7
38. Muljo, S.A., and M.S. Schlissel. 2000. Pre-B and pre-T-cell receptors: conservation of strategies in regulating early lymphocyte development. Immunol. Rev. 175:80-93. http://dx.doi.org/10.1111/j.1600-065X.2000 .imr017509.x
39. Naderi, S., K.B. Gutzkow, H.U. Låhne, S. Lefdal, W.J. Ryves, A.J. Harwood, and H.K. Blomhoff. 2004. cAMP-induced degradation of cyclin D3 through association with GSK-3beta. J. Cell Sci. 117:3769-3783. http:// dx.doi.org/10.1242/jcs.01210
40. Parker, M.J., S. Licence, L. Erlandsson, G.R. Galler, L. Chakalova, C.S. Osborne, G. Morgan, P. Fraser, H. Jumaa, T.H. Winkler, et al. 2005. The pre-B-cell receptor induces silencing of VpreB and lambda5 transcription. EMBO J. 24:3895-3905. http://dx.doi.org/10.1038/sj.emboj .7600850
41. Peng, S.L., A.J. Gerth, A.M. Ranger, and L.H. Glimcher. 2001. NFATc1 and NFATc2 together control both T and B cell activation and differentiation. Immunity. 14:13-20. http://dx.doi.org/10.1016/S1074- 7613(01)00085-1
42. Pozo, N., C. Zahonero, P. Fernández, J.M. Liñares, A. Ayuso, M. Hagiwara, A. Pérez, J.R. Ricoy, A. Hernández-Laín, J.M. Sepúlveda, and P. Sánchez-Gómez. 2013. Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth. J. Clin. Invest. 123:2475- 2487. http://dx.doi.org/10.1172/JCI63623
43. Rachdi L., D. Kariyawasam, V. Aiello, Y. Herault, N. Janel, J.M. Delabar, M. Polak, and R. Scharfmann. 2014. Dyrk1A induces pancreatic beta cell mass expansion and improves glucose tolerance. Cell Cycle. 13:2221-2229.
44. Rothenberg, E.V. 2014. Transcriptional control of early T and B cell developmental choices. Annu. Rev. Immunol. 32:283-321. http://dx.doi .org/10.1146/annurev-immunol-032712-100024
45. Sawai, C.M., J. Freund, P. Oh, D. Ndiaye-Lobry, J.C. Bretz, A. Strikoudis, L. Genesca, T. Trimarchi, M.A. Kelliher, M. Clark, et al. 2012. Therapeutic targeting of the cyclin D3:CDK4/6 complex in T cell leukemia. Cancer Cell. 22:452-465. http://dx.doi.org/10.1016/j.ccr.2012.09.016
46. Scales, T.M., S. Lin, M. Kraus, R.G. Goold, and P.R. Gordon-Weeks. 2009. Nonprimed and DYRK1A-primed GSK3 beta-phosphorylation sites on MAP1B regulate microtubule dynamics in growing axons. J. Cell Sci. 122:2424-2435. http://dx.doi.org/10.1242/jcs.040162
47. Schuh, W., S. Meister, K. Herrmann, H. Bradl, and H.M. Jäck. 2008. Transcriptome analysis in primary B lymphoid precursors following induction of the pre-B cell receptor. Mol. Immunol. 45:362-375. http:// dx.doi.org/10.1016/j.molimm.2007.06.154
48. Sicinska, E., I. Aifantis, L. Le Cam, W. Swat, C. Borowski, Q. Yu, A.A. Ferrando, S.D. Levin, Y. Geng, H. von Boehmer, and P. Sicinski. 2003. Requirement for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell. 4:451-461. http://dx.doi.org/10.1016/ S1535-6108(03)00301-5
49. Soppa, U., J. Schumacher, V. Florencio Ortiz, T. Pasqualon, F.J. Tejedor, and W. Becker. 2014. The Down syndrome-related protein kinase DYRK1A phosphorylates p27(Kip1) and Cyclin D1 and induces cell cycle exit and neuronal differentiation. Cell Cycle. 13:2084-2100. http:// dx.doi.org/10.4161/cc.29104
50. Teixeira, L.K., and S.I. Reed. 2013. Ubiquitin ligases and cell cycle control. Annu. Rev. Biochem. 82:387-414. http://dx.doi.org/10.1146/annurevbiochem- 060410-105307
51. Thompson, E.C., B.S. Cobb, P. Sabbattini, S. Meixlsperger, V. Parelho, D. Liberg, B. Taylor, N. Dillon, K. Georgopoulos, H. Jumaa, et al. 2007. Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits. Immunity. 26:335-344. http://dx.doi.org/10.1016/j.immuni.2007.02.010
52. Trapnell, C., A. Roberts, L. Goff, G. Pertea, D. Kim, D.R. Kelley, H. Pimentel, S.L. Salzberg, J.L. Rinn, and L. Pachter. 2012. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7:562-578. http://dx.doi.org/10 .1038/nprot.2012.016
53. Wegiel, J., C.X. Gong, and Y.W. Hwang. 2011. The role of DYRK1A in neurodegenerative diseases. FEBS J. 278:236-245. http://dx.doi.org/ 10.1111/j.1742-4658.2010.07955.x
54. Wu, L., C. Timmers, B. Maiti, H.I. Saavedra, L. Sang, G.T. Chong, F. Nuckolls, P. Giangrande, F.A. Wright, S.J. Field, et al. 2001. The E2F1-3 transcription factors are essential for cellular proliferation. Nature. 414:457-462. http://dx.doi.org/10.1038/35106593
55. Xie, W., T. Adayev, H. Zhu, J. Wegiel, A. Wieraszko, and Y.W. Hwang. 2012. Activity-dependent phosphorylation of dynamin 1 at serine 857. Biochemistry. 51:6786-6796. http://dx.doi.org/10.1021/bi2017798
56. Yabut, O., J. Domogauer, and G. D'Arcangelo. 2010. Dyrk1A overexpression inhibits proliferation and induces premature neuronal differentiation of neural progenitor cells. J. Neurosci. 30:4004-4014. http://dx.doi.org/ 10.1523/JNEUROSCI.4711-09.2010
57. Ye, X., G. Nalepa, M. Welcker, B.M. Kessler, E. Spooner, J. Qin, S.J. Elledge, B.E. Clurman, and J.W. Harper. 2004. Recognition of phosphodegron motifs in human cyclin E by the SCF(Fbw7) ubiquitin ligase. J. Biol. Chem. 279:50110-50119. http://dx.doi.org/10.1074/jbc .M409226200